| nuclear receptor subfamily 3, group C, member 1 |
DIAZEPAM |
Glucocorticoid |
31% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
DOXEPIN |
Melanocortin MC5 |
31% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
DIAZEPAM |
Protein Serine/Threonine Kinase, ERK2 |
31% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
DIAZEPAM |
Protein Serine/Threonine Kinase, ERK2 |
31% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
DICLOFENAC |
Protein Serine/Threonine Kinase, ERK1 |
31% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
DICLOFENAC |
Protein Serine/Threonine Kinase, ERK1 |
31% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
TRANILAST |
Protein Serine/Threonine Kinase, p38alpha |
31% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
TRANILAST |
Protein Serine/Threonine Kinase, p38alpha |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
FLURBIPROFEN |
Imidazoline I2, Central |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
FLURBIPROFEN |
Imidazoline I2, Central |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
TERAZOSIN |
ATPase, Na+/K+ |
31% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
TERAZOSIN |
ATPase, Na+/K+ |
31% |
NoneNone |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
TERAZOSIN |
ATPase, Na+/K+ |
31% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
MITOTANE |
Protein Tyrosine Kinase, Lck |
32% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
MITOXANTRONE |
Cannabinoid CB1 |
32% |
NoneNone |
NoneNone |
View
|
| melanocortin 4 receptor |
LEVOCARNITINE |
Melanocortin MC4 |
32% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 3 |
L-744832 |
Muscarinic M3 |
32% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
AZLOCILLIN |
Glucocorticoid |
32% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
FLUBENDAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
32% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
FLUBENDAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
32% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
SAQUINAVIR |
Testosterone |
32% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, alpha polypeptide |
NORETHINDRONE ACETATE |
Platelet-Derived Growth Factor (PDGF) |
32% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, alpha polypeptide |
NORETHINDRONE ACETATE |
Platelet-Derived Growth Factor (PDGF) |
32% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, beta polypeptide |
NORETHINDRONE ACETATE |
Platelet-Derived Growth Factor (PDGF) |
32% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, beta polypeptide |
NORETHINDRONE ACETATE |
Platelet-Derived Growth Factor (PDGF) |
32% |
NoneNone |
NoneNone |
View
|
| calcitonin receptor |
NADOLOL |
Calcitonin |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
RITONAVIR |
Serotonin 5-HT4 |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
RITONAVIR |
Serotonin 5-HT4 |
32% |
NoneNone |
NoneNone |
View
|
| opioid receptor, sigma 1 |
CYPROTERONE ACETATE |
Sigma1 |
32% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
NORGESTREL |
Protein Tyrosine Kinase, Fyn |
32% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
ALPHA-CYCLODEXTRIN |
Progesterone |
32% |
NoneNone |
NoneNone |
View
|
| progesterone receptor |
ALPHA-CYCLODEXTRIN |
Progesterone |
32% |
NoneNone |
NoneNone |
View
|
| FMS-like tyrosine kinase 1 |
TROXIPIDE |
Vascular Endothelinal Growth Factor (VEGF) |
32% |
NoneNone |
NoneNone |
View
|
| fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
TROXIPIDE |
Vascular Endothelinal Growth Factor (VEGF) |
32% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
SODIUM ORTHOVANADATE |
Thromboxane Synthetase |
32% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
SODIUM ORTHOVANADATE |
Thromboxane Synthetase |
32% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ACEBUTOLOL |
Monoamine Oxidase MAOA |
32% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
ACEBUTOLOL |
Monoamine Oxidase MAOA |
32% |
NoneNone |
NoneNone |
View
|
| opioid receptor, kappa 1 |
EBASTINE |
Opiate kappa |
32% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
EBASTINE |
Endothelin ETA |
32% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
ACEBUTOLOL |
Neuropeptide Y1 |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
AMPIROXICAM |
Serotonin 5-HT2B |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
PRAMOXINE |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
DEXFENFLURAMINE |
Sodium Channel, Site 2 |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
BENZOTHIAZYL DISULFIDE |
Adrenergic, Norepinephrine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
BENZOTHIAZYL DISULFIDE |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
BENZOTHIAZYL DISULFIDE |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
(S)-(-)-PINDOLOL |
Calcium Channel Type L, Phenylalkylamine |
32% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
CORTISONE |
Cyclooxygenase COX-1 |
32% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
CORTISONE |
Cyclooxygenase COX-1 |
32% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-2D6 monooxygenase |
MYRTECAINE |
CYP450-2D6 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
SPIRADOLINE |
Serotonin Transporter |
32% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
ERGOTAMINE |
Protein Serine/Threonine Kinase, ERK1 |
32% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
ERGOTAMINE |
Protein Serine/Threonine Kinase, ERK1 |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIHYDROERGOCRISTINE MESYLATE |
Calcium Channel Type L, Dihydropyridine |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
NITRENDIPINE |
Dopamine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| A3 adenosine receptor |
NITRENDIPINE |
Adenosine A3 |
32% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
PROMAZINE |
Protein Tyrosine Kinase, Fyn |
32% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
VX-745 |
Muscarinic M5 |
32% |
NoneNone |
NoneNone |
View
|
| melanocortin 5 receptor |
PAROXETINE |
Melanocortin MC5 |
32% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
NITRENDIPINE |
Phosphodiesterase PDE3 |
32% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
NITRENDIPINE |
Phosphodiesterase PDE3 |
32% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D3 |
NELFINAVIR |
Dopamine D3 |
32% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
TENOXICAM |
Neuropeptide Y1 |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
SEMUSTINE |
Serotonin 5-HT2A |
32% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
IDARUBICIN |
Protein Tyrosine Kinase, Fyn |
32% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TORSEMIDE |
CYP450-2C9 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
TORSEMIDE |
CYP450-2C9 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
TACRINE |
Serotonin 5-HT4 |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
TACRINE |
Serotonin 5-HT4 |
32% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
TACRINE |
Monoamine Oxidase MAOA |
32% |
NoneNone |
NoneNone |
View
|
| caspase 6 |
RIFABUTIN |
Protease, Caspase 1 |
32% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 2 |
RIFABUTIN |
Histamine H2 |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
FENBENDAZOLE |
Adrenergic, Norepinephrine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Phenylalkylamine |
31% |
NoneNone |
NoneNone |
View
|
| androgen receptor |
LEFLUNOMIDE |
Testosterone |
31% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
GLICLAZIDE |
Endothelin ETA |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, beta 3 |
LEFLUNOMIDE |
Adrenergic beta3 |
31% |
NoneNone |
NoneNone |
View
|
| matrix metallopeptidase 9 |
LEAD (II) ACETATE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
31% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
LEAD (II) ACETATE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
31% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Thromboxane Synthetase |
31% |
NoneNone |
NoneNone |
View
|
| thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Thromboxane Synthetase |
31% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
ETODOLAC |
CYP450-2C9 Inhibition |
31% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
ETODOLAC |
CYP450-2C9 Inhibition |
31% |
NoneNone |
NoneNone |
View
|
| opioid receptor, delta 1 |
RWJ-68354 |
Opiate delta |
31% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
PHENYTOIN |
CYP450-1A2 Inhibition |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
MITOXANTRONE |
Adrenergic alpha2C |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
MITOXANTRONE |
Adrenergic alpha2C |
31% |
NoneNone |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
LEAD (II) ACETATE |
Protein Tyrosine Kinase, Lck |
31% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
PROPRANOLOL |
Protein Tyrosine Kinase, Fyn |
31% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
MITOXANTRONE |
Serotonin 5-HT4 |
31% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
MITOXANTRONE |
Serotonin 5-HT4 |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1b |
IRINOTECAN |
Adrenergic alpha1B |
31% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
TROPISETRON |
Leukotriene C4 Synthetase |
31% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
TROPISETRON |
Leukotriene C4 Synthetase |
31% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 3, subfamily a, polypeptide 13 |
DIELDRIN |
CYP450-3A4 Inhibition |
31% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
L-744832 |
Adrenergic alpha1D |
31% |
NoneNone |
NoneNone |
View
|
| neuropeptide Y receptor Y1 |
ROTENONE |
Neuropeptide Y1 |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
TOLNAFTATE |
Calcium Channel Type L, Dihydropyridine |
31% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
BENZOTHIAZYL DISULFIDE |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
BENZOTHIAZYL DISULFIDE |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
BENZOTHIAZYL DISULFIDE |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| Sigma-2 Receptor |
DEXTROMETHORPHAN |
Sigma2 |
32% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
THIAMPHENICOL |
Melanocortin MC3 |
32% |
NoneNone |
NoneNone |
View
|
| melanocortin 3 receptor |
THIAMPHENICOL |
Melanocortin MC3 |
32% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
DYPHYLLINE |
Protein Serine/Threonine Kinase, ERK1 |
32% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
DYPHYLLINE |
Protein Serine/Threonine Kinase, ERK1 |
32% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
TICLOPIDINE |
Adrenergic alpha1D |
32% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
MEGESTROL ACETATE |
Phosphodiesterase PDE5 |
32% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
MEGESTROL ACETATE |
Phosphodiesterase PDE5 |
32% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
FLURANDRENOLIDE |
CYP450-1A2 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| Cytochrom P450-1A2 monooxygenase |
MEBENDAZOLE |
CYP450-1A2 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
R-(+)-PROPRANOLOL |
Imidazoline I2, Central |
32% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
R-(+)-PROPRANOLOL |
Imidazoline I2, Central |
32% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
ESTRIOL |
CYP450-2C9 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
ESTRIOL |
CYP450-2C9 Inhibition |
32% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine receptor 6 |
GENTIAN VIOLET |
Serotonin 5-HT6 |
32% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
TICRYNAFEN |
Glutamate, NMDA, Agonism |
32% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
GENTIAN VIOLET |
Platelet Activating Factor (PAF) |
32% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
ISOEUGENOL |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
ISOEUGENOL |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
ISOEUGENOL |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
ISOEUGENOL |
Adenosine Transporter |
32% |
NoneNone |
NoneNone |
View
|